In this episode, we’re excited to introduce Markus Gstöttner, the CEO of Clock.bio. Originally from Austria, Markus leads the innovative biotech company based in Cambridge that is redefining the future of regenerative medicine. Clock.bio specializes in using human-induced pluripotent stem cells (hiPSCs) to reverse cellular aging, aiming to significantly extend human healthspan. During our conversation, Markus will walk us through the company’s groundbreaking journey, the advanced CRISPR technology they are utilizing, and his aspirations for how these innovations could revolutionize treatments for age-related diseases. Join us as we explore the cutting-edge developments in biotechnology and Clock.bio’s pivotal role in this rapidly evolving field​.